companydata.dkNBCD A/S: Financial statements 2015
CVR: 30582462
NBCD A/S (CVR 30582462) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -6,080,089 and a net result of DKK 37,890,921 compared with DKK 29,158,907 the year before. Equity amounted to DKK 44,186,096. The solvency ratio was 41.5%.
- Gross Profit
- -6,080,089 kr.
- Profit/Loss
- 37,890,921 kr.
- Equity
- 44,186,096 kr.
- Total Assets
- 106,518,996 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -6.1 mio. | 37.9 mio. | 44.2 mio. | - |
| 2014 | - | 1.6 mio. | 29.2 mio. | 6.3 mio. | - |
| 2013 | - | -3.4 mio. | -11.8 mio. | -22.9 mio. | - |
| 2012 | - | - | - | 500 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
NBCD A/S has published its annual report for 2014. Gross profit came to DKK 1,579,482, and the net result was DKK 29,158,907.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The company is owned by Sanos Holding A/S. The company has 24 employees. In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity amounted to DKK 136,144,994.